Patent 7160899 was granted and assigned to Neurosearch A/S on January, 2007 by the United States Patent and Trademark Office.
This invention relates to the use of the combined action of a compound with neurotrophic activity and an adenosine A2A receptor antagonist for the treatment of Parkinson's disease.